JW Jungwoo Pharmaceutical Obtains International Standard Compliance Management System 'ISO37301' Certification

Shin Young-seop, CEO of JW Jungwoo Pharmaceutical (right), is taking a commemorative photo after receiving the ISO37301 certificate from Lee Won-gi, President of the Korea Compliance Certification Institute.

[Asia Economy Reporter Lee Gwan-joo] JW Pharmaceutical announced on the 3rd that it has obtained the ‘Compliance Management System International Standard (ISO37301)’ certification from the Korea Compliance Certification Institute.

ISO37301 is an international standard certification established by the International Organization for Standardization in April last year. It is awarded after evaluating whether the compliance policies and risk response systems that may occur throughout company management meet global standards and are operated effectively.

Since obtaining the ‘Anti-Bribery Management System International Standard (ISO37001)’ certification in 2018, JW Pharmaceutical has prepared to acquire the expanded concept of ISO37301 certification. To this end, since December last year, it has been promoting the internalization of compliance and ethical management through ▲establishing compliance policies ▲developing compliance manuals ▲training internal auditors ▲risk assessment by department ▲education and training.

JW Shinyak, an affiliate of JW Pharmaceutical, has also completed the first stage audit on the effectiveness of the ISO37001 system operation and is about to obtain certification. JW Group plans to strengthen the overall compliance management system of the group and further enhance corporate credibility, using JW Pharmaceutical’s ISO37301 certification as a turning point.

Lee Se-chan, Head of Compliance Management at JW Group, said, “To proactively lead ethical management that meets global standards, we have introduced the ISO37301 system to ensure compliance with all relevant laws, company regulations, and work guidelines,” adding, “We will accelerate ethical management by supporting the establishment of compliance and ethical management systems not only at JW Pharmaceutical and JW Shinyak but also at other affiliates, so that no legal violations or ethical breaches occur at the group level.”

This content was produced with the assistance of AI translation services.